Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 3Q Financial Report: AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

3Q Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

3Q Revenues: $44.2 million (flat)

3Q Earnings: $1.4 million (-68%)

YTD Revenues: $133.2 million (-8%)

YTD Earnings: $2.9 million (-83%)

Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract revenue for discovery services was $10.0 million, up 61%. Contract revenue from development and small scale manufacturing in the quarter was $9.6 million, up 45%. Large scale manufacturing revenues were $18.2 million, down 2%. Results for the quarter and YTD reflect a reduction in Allegra royalties, as well as the effects on large scale manufacturing due to the discontinuation of one product supplied to GE Healthcare in 2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters